<?xml version="1.0" encoding="UTF-8"?>
<ref id="B30-antibiotics-09-00428">
 <label>30.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Safieh-Garabedian</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Poole</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Allchorne</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Winter</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Woolf</surname>
    <given-names>C.J.</given-names>
   </name>
  </person-group>
  <article-title>Contribution of interleukin-1 to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia</article-title>
  <source>Br. J. Pharm.</source>
  <year>1995</year>
  <volume>115</volume>
  <fpage>1265</fpage>
  <lpage>1275</lpage>
  <pub-id pub-id-type="doi">10.1111/j.1476-5381.1995.tb15035.x</pub-id>
  <?supplied-pmid 7582555?>
  <pub-id pub-id-type="pmid">7582555</pub-id>
 </element-citation>
</ref>
